| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 112.93B | 115.12B | 110.58B | 104.38B | 108.28B | 92.64B |
| Gross Profit | 34.47B | 34.57B | 33.94B | 31.16B | 33.73B | 29.14B |
| EBITDA | 19.99B | 20.38B | 19.06B | 15.71B | 16.89B | 13.52B |
| Net Income | 10.27B | 9.90B | 9.43B | 8.67B | 8.53B | 6.31B |
Balance Sheet | ||||||
| Total Assets | 145.76B | 153.00B | 152.99B | 140.78B | 135.36B | 122.58B |
| Cash, Cash Equivalents and Short-Term Investments | 41.42B | 50.07B | 44.90B | 42.45B | 46.90B | 48.75B |
| Total Debt | 1.95B | 0.00 | 755.00M | 133.00M | 219.00M | 0.00 |
| Total Liabilities | 24.28B | 23.45B | 29.83B | 27.81B | 30.23B | 28.24B |
| Stockholders Equity | 121.48B | 129.55B | 123.15B | 112.97B | 105.13B | 94.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.38B | 5.33B | -2.60B | -1.28B | 5.60B |
| Operating Cash Flow | 0.00 | 14.45B | 16.01B | 11.97B | 9.12B | 9.76B |
| Investing Cash Flow | 0.00 | -4.75B | -10.98B | -12.31B | -11.20B | -9.66B |
| Financing Cash Flow | 0.00 | -5.45B | -4.90B | -4.15B | -2.50B | -2.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥180.84B | 22.82 | ― | 2.84% | 4.10% | 5.25% | |
74 Outperform | ¥543.60B | 15.11 | 6.52% | 1.82% | 4.95% | 52.94% | |
73 Outperform | ¥327.64B | 9.57 | 5.47% | 3.41% | 0.55% | 25.37% | |
73 Outperform | ¥401.13B | 9.42 | 9.59% | 3.91% | -2.06% | 46.42% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ¥796.81B | 20.28 | 2.01% | 3.82% | -7.76% | 7.92% | |
55 Neutral | ¥300.16B | -3.18 | 9.34% | 4.27% | -1.18% | -78.57% |